China must strengthen regulation of its market for vaccines, the World Health Organization (WHO) said on Monday, after a bust of an illegal black market drugs ring this month underscored the country’s regulatory weaknesses. Police have arrested more than 130 suspects over a scandal in which 310 million yuan ($48 million) of illegal vaccines was […]
Novartis AG is under pressure from the U.S. Attorney’s office in Manhattan to provide information about 80,000 “sham” events.
Hyberabad, India-based Dr. Reddy’s Laboratories announced today that it had inked a licensing deal with Santa Clara, Calif.-based XenoPort worth more than $490 million.
March 28, 2016 By Alex Keown, BioSpace.com Breaking News Staff WOODCLIFF LAKE, N.J. – Shares of Eagle Pharmaceuticals EGRX)are down about 8 percent this morning after the U.S. Food and Drug Administration rejected the company’s request for seven years of orphan drug exclusivity in the U.S. for its blood cancer drug, Bendeka. The regulatory […]
While every medical case is unique, payers and providers are attempting to standardize treatment since unnecessary variation is a major source of growing costs.
U.S. doctors and hospitals throw out almost $3 billion (roughly 2.7 billion euros) in unused cancer drugs each year because the medicines come in supersized single-use packages and excess medicine must be discarded for safety reasons, a recent paper suggests. Researchers focused on 20 expensive medicines that are given by injection or intravenous drip and […]
The Clinical Specialist Model and the Service Rep Model are considered two of the most successful innovative approaches in S&M for pharmaceutical companies.
The FDA sent a warning letter to Terumo Corp. over issues with the manufacturing and quality control of its Destination Guiding vascular sheaths.
The analysts at Thomson Reuters have consulted their crystal balls and come up with seven drugs coming out this year that will likely hit blockbuster status – defined as marking more than $1 billion annually.
March 25, 2016By Alex Keown, BioSpace.com Breaking News Staff FOSTER CITY, Calif. – Although Gilead Sciences (GILD) is in the midst of a legal battle that could cost it about $3 billion, the Foster City-based company snapped up property in the San Francisco Bay area that could provide 800,000 square-feet of space in an […]